These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 239250

  • 1. Cardiac adenylate cyclase activity in relation to beta-adrenergic responses.
    Wollemann M, Borbola J, Papp J, Szekeres L.
    J Mol Cell Cardiol; 1975 Jul; 7(7):523-33. PubMed ID: 239250
    [No Abstract] [Full Text] [Related]

  • 2. [Hydroxybenzylpindolol--activation mechanism of adenylate cyclase and beta-adrenergic receptor].
    Yamamura H.
    Nihon Rinsho; 1976 Jul; 34(3):534-9. PubMed ID: 6811
    [No Abstract] [Full Text] [Related]

  • 3. Catecholamine-sensitive adenylate cyclase of human fat cell ghosts: a comparative study using different beta-adrenergic agents.
    Kather H, Simon B.
    Metabolism; 1977 Nov; 26(11):1179-84. PubMed ID: 20550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the beta-adrenoceptors.
    Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):13-8. PubMed ID: 6116196
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y, Sakuma I, Nakao Y, Kanno M.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [Abstract] [Full Text] [Related]

  • 9. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M, Mittmann C, Schwinger RH, Erdmann E.
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [Abstract] [Full Text] [Related]

  • 10. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
    Bilezikian JP, Dornfeld AM, Gammon DE.
    Biochem Pharmacol; 1978 May 15; 27(10):1445-54. PubMed ID: 29638
    [No Abstract] [Full Text] [Related]

  • 11. Heterogeneity of adenylate cyclase-coupled beta-adrenergic receptors.
    Lefkowitz RJ.
    Biochem Pharmacol; 1975 Mar 01; 24(5):583-90. PubMed ID: 235928
    [No Abstract] [Full Text] [Related]

  • 12. Cholinergic antagonism of beta-adrenergic stimulated action potentials and adenylate cyclase activity in rabbit ventricular cardiomyocytes.
    Watson JM, Vogel SM, Cotterell DJ, Dubocovich ML.
    Eur J Pharmacol; 1988 Oct 11; 155(1-2):101-8. PubMed ID: 2468508
    [Abstract] [Full Text] [Related]

  • 13. Editorial: Selectivity in beta-adrenergic responses: clinical implications.
    Lefkowitz RJ.
    Circulation; 1974 May 11; 49(5):783-6. PubMed ID: 4151328
    [No Abstract] [Full Text] [Related]

  • 14. Exfoliation of the beta-adrenergic receptor and the regulatory components of adenylate cyclase by cultured rat glioma C6 cells.
    Kassis S, Lauter CJ, Stojanov M, Salem N.
    Biochim Biophys Acta; 1986 May 29; 886(3):474-82. PubMed ID: 2871868
    [Abstract] [Full Text] [Related]

  • 15. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ.
    Z Kardiol; 1983 Feb 29; 72(2):63-82. PubMed ID: 6133398
    [Abstract] [Full Text] [Related]

  • 16. The resolution of dopamine and beta 1- and beta 2-adrenergic-sensitive adenylate cyclase activities in homogenates of cat cerebellum, hippocampus and cerebral cortex.
    Dolphin A, Hamont M, Bockaert J.
    Brain Res; 1979 Dec 28; 179(2):305-17. PubMed ID: 41616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium.
    Baumann G, Felix SB, Heidecke CD, Riess G, Loher U, Ludwig L, Blömer H.
    Agents Actions; 1984 Oct 28; 15(3-4):216-28. PubMed ID: 6151806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.